Home / Stock ratings / VTR
Stock rating · Real Estate Investment Trusts
Ventas, Inc. (VTR) Stock Rating & Analysis
As of October 13, 2026, MELANY rates Ventas, Inc. 49 out of 100 (Neutral). Its highest factor score is dividend safety at 86, and its lowest is value (P/FFO) at 17.
MELANY ratingRated 2026-10-13VTR · composite score
About Ventas, Inc.
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care sectors, including almost 100 properties in Canada and the United Kingdom, as it seeks further investment in countries whose healthcare systems are mature and operate similarly to that of the US. It also owns mortgages and other loans contributing about 1% of net operating income.
Rating as of 2026-10-13 · this is a dated snapshot; the live rating is in the app (Pro, free for 30 days). The price above updates in real time.
Why VTR scores 49/100
VTR's 8 factor scores run from 17 to 86, and 4 of them sit above its composite of 49. Here is how VTR breaks down.
Price against funds from operations, the REIT equivalent of earnings.
Leverage, debt maturity and balance-sheet resilience.
- Conservative balance sheet for a REIT (0.8x debt/equity)
Direction and relative strength of the recent price trend.
- Below the 200-day MA, structural downtrend
How well the distribution is covered by funds from operations.
- Distribution well covered, 63% of FFO
Performance against other REITs and the broad market.
Whether the current move looks durable or stretched.
Return weighed against volatility and drawdown.
How the current rate environment and property cycle suit this REIT.
- Rising 10-year yields are a headwind for REIT valuations
How VTR compares
Some other companies with a MELANY rating page in its SEC industry group (Real Estate Investment Trusts).
Key risks for VTR
- Rising 10-year yields are a headwind for REIT valuations
- Below the 200-day MA, structural downtrend
Tracking VTR
Ventas, Inc. rates Neutral right now, so MELANY is not flagging a fresh entry. Add VTR to a watchlist in the app to follow its rating; an alert the moment it changes is part of Pro, free for 30 days.
How MELANY rates VTR
MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. Ventas, Inc.'s 49/100 reflects reit factor weighting for its profile.
Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.
Frequently asked questions about VTR
Is Ventas, Inc. (VTR) a buy?
As of 2026-10-13, MELANY rated Ventas, Inc. Neutral with a composite score of 49/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.
What is Ventas, Inc.'s MELANY score?
Ventas, Inc. (VTR) has a MELANY composite score of 49/100, combining value (p/ffo), balance sheet, trend & structure, dividend safety, relative strength, momentum quality, risk-adj. return, rate & property fit.
How is the VTR stock rating calculated?
MELANY scores VTR from 0 to 100 across eight weighted factors using live market and fundamental data, then refreshes the rating automatically as new data arrives.
Should I buy Ventas, Inc. stock?
That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates Ventas, Inc. (VTR) Neutral with a composite of 49/100 as of 2026-10-13. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.
What is the VTR stock price forecast?
MELANY does not publish price targets or forecasts for VTR. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 49/100 across eight factors for Ventas, Inc., and re-scores automatically as new price, earnings, and fundamental data arrive.
Is VTR stock overvalued or undervalued?
MELANY's value (p/ffo) factor currently reads 17/100 for Ventas, Inc., where a higher score means the price looks more attractive on that measure. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives VTR's read.
What price should I buy VTR at?
MELANY is not flagging a fresh entry for VTR at its current Neutral rating, so there is no entry zone to publish right now. Add VTR to a watchlist in the app to follow it; an alert the moment the rating changes is part of Pro, free for 30 days.
What are the risks of buying VTR stock?
The top risks MELANY currently flags for Ventas, Inc.: Rising 10-year yields are a headwind for REIT valuations; Below the 200-day MA, structural downtrend. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.
Is Ventas, Inc. a good long-term investment?
For long-term durability the two factors that matter most are balance sheet, which MELANY scores 54/100 for Ventas, Inc., and dividend safety, at 86/100. The 49/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.
Will VTR stock go up?
Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's trend & structure factor reads 49/100 for VTR right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.
How current is this VTR rating?
The rating on this page is a snapshot of MELANY's read as of 2026-10-13. The price shown updates live, but the score is not recomputed on this page. MELANY re-scores VTR continuously as new price, earnings, and fundamental data arrive, and the current rating is in the app (Pro, free for 30 days).
How this rating works
Market Eyes Live
Every rating graded in public, VTR included
MELANY scores more than 11,000 U.S. stocks and ETFs, PRISM ranks conviction and APEX writes the plan with one entry zone. Free to start on iOS and the web.